Skip to main content

Table 1 Characteristics of borderline malignancy and epithelial ovarian cancer cases

From: GPR30 regulates the EGFR-Akt cascade and predicts lower survival in patients with ovarian cancer

Variables Number of patients (%)
  N=162
Age (years) 54.1 ± 12.5
Postmenopausal 96
Premenopausal 66
BMI 22.0 ± 3.4
Histology Borderline malignancy 10 (6.1%)
Serous adenocarcinoma 61 (37.6%)
Endometrioid adenocarcinoma 30 (18.5%)
Mucinous adenocarcinoma 19 (11.7%)
Clear cell adenocarcinoma 29 (17.9%)
Other 13 (8.0%)
FIGO stage I 49 (30.2%)
     II 14 (8.6%)
     III 77 (47.5%)
     IV 22 (13.5%)